EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma

Simone De Leo iD, Valeria Bottici, Gabriella Pellegriti, Marco Russo, Caterina Mian iD, Federica Vianello, Barbara Puligheddu, Gerdi Tuli, Rita Ortolano, Maria Grazia Castagna, Carlotta Pozza, Malgorzata Gabriela Wasniewska und 14 weitere

Thyroid® · 2025

DOI: 10.1177/10507256251363978 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Thyroid®, 2025. Verfasst von Simone De Leo und 25 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Oncology Unit, Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Differentiated thyroid carcinoma (DTC) in pediatric patients has specific clinical, pathological, and molecular characteristics, making its management different from that of adults. Our study aimed to evaluate the outcome and factors associated with persistent disease in a large cohort of pediatric patients.

Methods

We performed a multicenter retrospective cohort study, including patients aged ≤18 years, diagnosed with a DTC, since January 2000. Both biochemical (BIR) and structural (SIR) incomplete responses were evaluated.

Results

We included 538 patients, 401/538 (74.5%) females, with a median age of 15 years (interquartile range [IQR] 13–17 years). Papillary thyroid cancer was the most prevalent histotype and 277/530 (52.3%) had lymph node metastases at diagnosis. Vascular invasion and gross extrathyroidal extension (ETE) were reported in 133/326 (40.8%) and 91/533 (17.1%) of patients, respectively. T4 tumors represented 5% of the entire cohort. Radioactive iodine treatment (RAIT) was administered to 493/533 (92.5%) patients, and among them 138/493 (28%) received more than one RAIT cycle. After a median follow-up of 85 months (IQR 42–126 months), 414/538 patients (77%) had no evidence of disease and 124/538 patients (23.0%) a disease persistence: BIR in 68/538 patients (12.6%) and SIR in 56/538 patients (10.4%). In a multivariable analysis, the features significantly associated with persistent disease (BIR or SIR) were gross ETE (odds ratio [OR] 2.81, confidence interval [CI] 1.49–5.32, p = 0.0015) and lymph node uptake at whole-body scan (WBS) after the first RAIT (OR 3.31, CI 1.77–6.19, p = 0.0002). Multivariable analysis showed that the features significantly associated with SIR were T4 tumor (OR 4.3, CI 1.38–13.44, p = 0.01) and lymph node uptake at WBS after the first RAIT (OR 3.39, CI 1.5–7.67, p = 0.003).

Conclusions

Our study of a very large series of pediatric DTC with long follow-up provides valuable insights into the clinical and pathological features associated with disease persistence. We identified T4 tumor, lymph node uptake on WBS, and gross ETE as independent factors associated with persistent disease. These findings emphasize the importance of careful risk stratification in pediatric DTC, allowing for more individualized treatment approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinomaHumansFemaleMaleAdolescentRetrospective StudiesChildIodine RadioisotopesThyroid Cancer, PapillaryLymphatic MetastasisCarcinoma, PapillaryChild, PreschoolTreatment Outcome

Stichwörter der Autor:innen

childrendifferentiated thyroid carcinomadisease persistenceoutcomepediatric thyroid cancer

Substanzen

Iodine Radioisotopes

Autor:innen und Institutionen

  • Endocrine Oncology Unit, Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.
  • Endocrine Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.
  • Endocrinology Division, Garibaldi Nesima Hospital, Catania, Italy.
  • Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padova, Italy.
  • Department of Radiotherapy, Istituto Oncologico Veneto-IRCCS, Padua, Italy.

ORCID-Profile: Simone De Leo, Caterina Mian, Maria Laura Tanda, Rossella Elisei

Zitieren

APA

De Leo, S., Bottici, V., Pellegriti, G., Russo, M., Mian, C., Vianello, F., Puligheddu, B., Tuli, G., Ortolano, R., Castagna, M. G., Pozza, C., Wasniewska, M. G., Cabria, M., Rochira, V., Brigante, G., Felicetti, F., Vigone, M. C., Zatelli, M. C., Esposito, G., …, & Elisei, R. (2025). Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma. Thyroid®. https://doi.org/10.1177/10507256251363978

Vancouver

De Leo S, Bottici V, Pellegriti G, Russo M, Mian C, Vianello F, et al. Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma. Thyroid®. 2025. doi:10.1177/10507256251363978

BibTeX
@article{DeLeo2025,
  author = {De Leo, Simone and Bottici, Valeria and Pellegriti, Gabriella and Russo, Marco and Mian, Caterina and Vianello, Federica and Puligheddu, Barbara and Tuli, Gerdi and Ortolano, Rita and Castagna, Maria Grazia and Pozza, Carlotta and Wasniewska, Malgorzata Gabriela and Cabria, Manlio and Rochira, Vincenzo and Brigante, Giulia and Felicetti, Francesco and Vigone, Maria Cristina and Zatelli, Maria Chiara and Esposito, Gerardo and Dolci, Alessia and Arvat, Emanuela and Giorgino, Francesco and Giachetti, Marcello and Tanda, Maria Laura and Fugazzola, Laura and Elisei, Rossella},
  title = {Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma},
  journal = {Thyroid®},
  year = {2025},
  doi = {10.1177/10507256251363978}
}
Kostenlos starten →